Loading your page…
Each register with its number of medicines and a few of them.
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
FDA · 14 medicines
SFDA · 8 medicines · Historical list
PHARMAC · 7 medicines
Show all 7CBG-MEB · 6 medicines
AEMPS · 5 medicines
AIFA · 4 medicines
HSA · 4 medicines
MS · 3 medicines · Historical list
TFDA · 1 medicine · Historical list
Every register, a page at a time. Strengths and packs are on each medicine’s page.
7 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Dilantin Paediatric | New Zealand | Oral liq 30 mg per 5 ml | Funded | ||
| Dilantin | New Zealand | Cap 30 mg | Funded | ||
| Dilantin | New Zealand | Cap 100 mg | Funded | ||
| Dilantin Infatab | New Zealand | Tab 50 mg | Funded | ||
| Any | New Zealand | Cap 30 mg | Funded | ||
| Any | New Zealand | Oral liq 6 mg per ml | Funded | ||
| Hospira | New Zealand | Inj 50 mg per ml, 5 ml ampoule | Funded |
The same brand on several registers.
The companies holding its medicines, the most first.
Substances it shares a medicine with.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of AEMPS, AIFA, Anvisa, CBG-MEB, FDA, Health Canada, HSA, MS, PHARMAC, SFDA and TFDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
